LivingGLP1
Study S002613

Effect of Weight Loss on Cardiac Function and Biomarkers in Patients With Cardiovascular Risk Factors, Obesity, or Overweight

Registration

Registration
NCT07455630
Acronym
BEYOND
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
30
Start
2023-06-20
Primary completion
2023-09-19
Lead sponsor
TecSalud Investigación Clínica
Conditions
Obesity & Overweight
Interventions
DRUG:Weight loss with pharmacotherapy; BEHAVIORAL:Weight loss without pharmacotherapy
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Left Ventricular Mass by Cardiac MRI [Baseline, 3 months, 6 months, and 9 months.]
  • Right Ventricular Mass by Cardiac MRI [Baseline, 3 months, 6 months, and 9 months.]
  • Left Ventricular Ejection Fraction [Baseline, 3 months, 6 months, and 9 months.]
  • Right Ventricular Ejection Fraction [Baseline, 3 months, 6 months, and 9 months.]
  • Diastolic Function Left Ventricle [Baseline, 3 months, 6 months, and 9 months.]
  • Diastolic Function Right Ventricle [Baseline, 3 months, 6 months, 9 months.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.